Harpoon Therapeutics, Inc.

53
Hold
  • Market Cap: Micro Cap
  • Industry: Biotechnology
  • ISIN: US41358P2056
USD
23.01
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Harpoon Therapeutics, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Dec'17
No of Months
12
12
12
12
12
12
Profit Before Tax
-67.00
-116.00
-49.00
-55.00
-27.00
-16.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-33.00
-19.00
33.00
49.00
-1.00
17.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-89.00
-122.00
-8.00
-2.00
-27.00
1.00
Cash Flow from Investing Activities
89.00
34.00
-63.00
-69.00
0.00
4.00
Cash Flow from Financing Activities
6.00
111.00
4.00
71.00
88.00
22.00
Net Cash Inflow / Outflow
6.00
23.00
-67.00
0.00
60.00
28.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Harpoon Therapeutics, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
-67.731
-77.137
10.00
12.19%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-33.578
0
-33.00
0.00%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-89.182
0
-89.00
0.00%
Cash Flow from Investing Activities
89.737
0
89.00
0.00%
Cash Flow from Financing Activities
6.372
0
6.00
0.00%
Net Cash Inflow / Outflow
6.927
0
6.00
0.00%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'22
stock-summary

YoY Growth in year ended Dec 2022 is 26.99% vs -1,317.76% in Dec 2021

Dec'22
Dec'21
Change(%)
Cash Flow from Operating Activities
-89.18
-122.15
26.99%